Evidence mapPaperPMID 42561408Full record

ArticleJMIR mHealth and uHealth2026

Utility of Tablet-Based Eye Tracking for Early Screening of Poststroke Cognitive Impairment: Diagnostic Cohort Study.

Boxu Xie, Ronghui Ren, Yuting Zhang, Xuan Wang, Junli Zhen

Abstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boxu XieKey Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China, 86 1-383-112-9670.ORCID http://orcid.org/0009-0004-7139-0509
Ronghui RenKey Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China, 86 1-383-112-9670.ORCID http://orcid.org/0009-0000-2437-0768
Yuting ZhangKey Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China, 86 1-383-112-9670.ORCID http://orcid.org/0009-0003-7566-125X
Xuan WangKey Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China, 86 1-383-112-9670.ORCID http://orcid.org/0009-0003-1986-6963
Junli ZhenKey Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China, 86 1-383-112-9670.ORCID http://orcid.org/0000-0002-7701-4756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Poststroke cognitive impairment (PSCI) is a common and disabling complication after stroke; however, early screening remains challenging due to limited access to neuropsychological testing and the high cost of neuroimaging. Portable, tablet-based eye-tracking technology may offer a scalable, low-cost solution for early PSCI detection. Objective: This study aimed to evaluate the clinical utility of a tablet-based, AI-driven eye-tracking system for early screening of PSCI at 3 months after acute ischemic stroke. We sought to quantify oculomotor-cognitive associations and develop a practical nomogram for individualized risk prediction. Methods: We prospectively enrolled 142 hospitalized patients with acute cerebral infarction between May 2023 and October 2024, of whom 122 completed the 3-month follow-up and were included in the final analysis, along with 20 healthy community-dwelling controls. All patients underwent tablet-based eye tracking (visual paired comparison and antisaccade tasks) during the acute phase, as well as baseline and 3-month neuropsychological assessments. PSCI was defined using validated cutoffs. Multivariable logistic regression was used to identify independent predictors, and a nomogram was constructed. Internal validation was performed using bootstrap resampling (1000 samples). Results: At 3 months, out of 122 patients, 47 (38.5%) met PSCI criteria. Compared with patients with non-PSCI (n=75), patients with PSCI showed significantly prolonged correct saccade latency (median 322.96, IQR 209.45-445.59 ms vs 194.55, IQR 141.50-299.75 ms; Z=-4.03, P<.001), increased uncorrected error rate (median 30.00%, IQR 15.00%-42.00% vs 5.00%, IQR 0.00%-28.00%; Z=-4.24, P<.001), and reduced novelty preference ratio (median 1.44, IQR 0.97-1.70 vs 2.12, IQR 1.27-4.56; Z=-3.44, P=.001). Multivariable analysis identified 4 independent predictors of 3-month PSCI: older age (odds ratio [OR] 1.067 per year, 95% CI 1.009-1.129; P=.02), lower education level (OR 0.841 per year, 95% CI 0.708-0.999; P=.049), higher NIHSS (National Institutes of Health Stroke Scale) scores (OR 1.557 per point, 95% CI 1.075-2.256; P=.02), and prolonged correct saccade latency (OR 1.004 per ms, 95% CI 1.000-1.007; P=.04). A nomogram incorporating these 4 factors achieved good discriminative performance (area under the receiver operating characteristic curve 0.86, 95% CI 0.793-0.927) with satisfactory calibration. Conclusions: Age, education, admission NIHSS, and correct saccade latency were identified as possible independent predictors of 3-month PSCI in this cohort. The tablet-based eye-tracking system, when combined with clinical variables, may represent a feasible approach for early PSCI screening. A nomogram based on these variables demonstrated high accuracy and potential clinical utility for early PSCI identification. This approach may facilitate early identification of high-risk patients and enable timely, personalized interventions in resource-limited settings.

Indexed as

Cognitive DysfunctionComputers, HandheldEye-Tracking TechnologyMass ScreeningStrokeAgedCohort StudiesEarly DiagnosisFemaleHumansLogistic ModelsMaleMiddle AgedNeuropsychological TestsProspective Studiesacute ischemic strokecognitive screeningeye trackingmobile health technologypoststroke cognitive impairmenttablet assessment

Identifiers

PMID42561408
PMCPMC13446795

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.